Dimensional Fund Advisors
AVBP icon

Dimensional Fund Advisors’s ArriVent BioPharma AVBP Stock Holding History

Dimensional Fund Advisors’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92M Buy
126,525
+111,782
+758% +$2.52M ﹤0.01% 2627
2025
Q4 		$297K Buy
14,743
+585
+4% +$12.2K ﹤0.01% 3045
2025
Q3 		$261K Buy
+14,158
New +$278K ﹤0.01% 3086

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors's AVBP Position: Q1 2026 in Review

Dimensional Fund Advisors increased its ArriVent BioPharma (AVBP) stake by 758% in Q1 2026, buying an estimated $2.52M and bringing the position to 126,525 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2627.

Dimensional Fund Advisors first reported a position in AVBP in Q3 2025 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Dimensional Fund Advisors held 126,525 shares of ArriVent BioPharma worth $2.92M as of Q1 2026.
  • Dimensional Fund Advisors bought 111,782 ArriVent BioPharma shares in Q1 2026, an estimated $2.52M.
  • ArriVent BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2627 holding.
  • Dimensional Fund Advisors first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 3 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.